Cargando…
Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinoma
Renal cell carcinoma (RCC) is a highly vascularized and immunogenic tumor, being an ideal candidate for checkpoint blockade-based immunotherapy. Accordingly, checkpoint inhibitors have demonstrated clinical efficacy in patients with metastatic RCC (mRCC). Sex-specific differences in cancer immunothe...
Autores principales: | Tulchiner, Gennadi, Pichler, Renate, Ulmer, Hanno, Staudacher, Nina, Lindner, Andrea Katharina, Brunner, Andrea, Zelger, Bettina, Steinkohl, Fabian, Aigner, Friedrich, Horninger, Wolfgang, Thurnher, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423679/ https://www.ncbi.nlm.nih.gov/pubmed/33646368 http://dx.doi.org/10.1007/s00262-021-02882-y |
Ejemplares similares
-
Immune-related lichenoid mucocutaneous erosions during anti-PD-1 immunotherapy in metastatic renal cell carcinoma - A case report
por: Lindner, Andrea Katharina, et al.
Publicado: (2018) -
CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma
por: Tulchiner, Gennadi, et al.
Publicado: (2021) -
Adenomatoid tumor of the testis mimicking malignant testicular cancer on multiparametric ultrasound
por: Pichler, Renate, et al.
Publicado: (2018) -
Lynch Syndrome: Its Impact on Urothelial Carcinoma
por: Lindner, Andrea Katharina, et al.
Publicado: (2021) -
High IDO‐1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma
por: Seeber, Andreas, et al.
Publicado: (2018)